{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:41:16Z","timestamp":1777387276484,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jceh.2021.06.018","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T20:20:53Z","timestamp":1624652453000},"page":"428-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Changes in Serum Interferon Gamma and Interleukin-10 in Relation to Direct-Acting Antiviral Therapy of Chronic Hepatitis C Genotype 4: A Pilot Study"],"prefix":"10.1016","volume":"12","author":[{"given":"Mohamed M.","family":"Nabeel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania K.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-2230","authenticated-orcid":false,"given":"Wafaa","family":"Alakel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabab","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1763-6887","authenticated-orcid":false,"given":"Hossam","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Elbeshlawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr","family":"Abul-Fotouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend I.","family":"Shousha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5893-0513","authenticated-orcid":false,"given":"Mohamad","family":"Saeed Marie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.06.018_bib1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jvh.12123","article-title":"Viral hepatitis and the global burden of disease: a need to regroup","volume":"20","author":"Cooke","year":"2013","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jceh.2021.06.018_bib2","series-title":"Global Hepatitis Report 2017","year":"2017"},{"key":"10.1016\/j.jceh.2021.06.018_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2021.06.018_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1155\/2010\/692036","article-title":"Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C","volume":"24","author":"Livingston","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.06.018_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrgastro.2010.219","article-title":"Hepatitis in 2010: the dawn of a new era in HCV therapy","volume":"8","author":"Ciesek","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.06.018_bib6","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/hep.26218","article-title":"Chronic hepatitis C virus (HCV) disease burden and cost in the United States","volume":"57","author":"Razavi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.06.018_bib7","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.06.018_bib8","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.4254\/wjh.v7.i19.2202","article-title":"Dendritic cells: the warriors upfront-turned defunct in chronic hepatitis C infection","volume":"7","author":"Sachdeva","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2021.06.018_bib9","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3748\/wjg.v22.i4.1393","article-title":"Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C","volume":"22","author":"Crosignani","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.06.018_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/imr.12090","article-title":"Natural killer cells: multifaceted players with key roles in hepatitis C immunity","volume":"255","author":"Golden-Mason","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jceh.2021.06.018_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cyto.2017.04.008","article-title":"Cytokine profile in chronic hepatitis C: an observation","volume":"96","author":"Baskic","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.jceh.2021.06.018_bib12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.humimm.2014.08.198","article-title":"Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-\u03b1 polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients","volume":"75","author":"Tarrag\u00f4","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jceh.2021.06.018_bib13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hep.27971","article-title":"Temporal dynamics of inflammatory cytokines\/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection","volume":"62","author":"Carlin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.06.018_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"Electronic address: easloffice@easloffice.eu. EASL Recommendations on Treatment of Hepatitis C 2016","volume":"66","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.06.018_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/79734","article-title":"Dendritic cell regulation of TH1-TH2 development","volume":"1","author":"Moser","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jceh.2021.06.018_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8578051","article-title":"Restoring inflammatory mediator balance after sofosbuvir-induced viral clearance in patients with chronic hepatitis C","author":"Saraiva","year":"2018","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jceh.2021.06.018_bib17","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jceh.2021.06.018_bib18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T\u00a0cell exhaustion","volume":"12","author":"Jun","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jceh.2021.06.018_bib19","first-page":"670","article-title":"Impact of direct-acting antiviral agents on the development of hepatocellular carcinoma:\u00a0evidence and pathophysiological issues","volume":"31","author":"Tampaki","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jceh.2021.06.018_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.gastro.2015.03.004","article-title":"Successful interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function","volume":"149","author":"Serti","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.06.018_bib21","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/infdis\/jiw457","article-title":"Direct-acting antiviral-induced hepatitis C virus clearance does not completely restore the altered cytokine and chemokine Milieu in patients with chronic hepatitis C","volume":"214","author":"Hengst","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2021.06.018_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.06.018_bib23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/cmi.2014.119","article-title":"Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients","volume":"12","author":"Zhai","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jceh.2021.06.018_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4110\/in.2016.16.6.330","article-title":"Regulatory T cells in hepatitis B and C virus infections","volume":"16","author":"Jung","year":"2016","journal-title":"Immune Netw"},{"key":"10.1016\/j.jceh.2021.06.018_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/liv.13256","article-title":"Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index","volume":"37","author":"Bachofner","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.06.018_bib26","article-title":"Nutritional status and liver steatosis after direct-acting antiviral treatment for chronic hepatitis C virus infection","volume":"3","author":"Shimada","year":"2017","journal-title":"J\u00a0TranslSci"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321001626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321001626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:11:55Z","timestamp":1760854315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321001626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0973688321001626"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.06.018","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in Serum Interferon Gamma and Interleukin-10 in Relation to Direct-Acting Antiviral Therapy of Chronic Hepatitis C Genotype 4: A Pilot Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}